| ³«ºÅǯ·î |
³Ø²ñ̾ |
±é¼Ô |
±éÂê̾ |
| 2006ǯ1·î |
Âè21²óÆüËÜÀÅÌ®·ÐIJ±ÉÍܳزñ |
°ÂÆ£·ò¼£ |
NST²ðÆþ¤Ë¤è¤ë±ÉÍÜÊäµë·ÁÂÖ¤ÎÊѲ½ |
| 2006ǯ2·î |
Âè84²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
»°ÅÄ·ÉÆó |
RFA¼£ÎŤˤª¤±¤ë³°²ÊŪ´ØÍ¿¤Î͸úÀ |
| 2006ǯ3·î |
Âè76²óÆüËܾò½´ïÆâ»ë¶À³Ø²ñÃÏÊý²ñ |
°ÂÆ£·ò¼£ |
Ç´±Õ»ºÀ¸ÃÀ´É¼ðáç¤Î°ìÎã |
| 2006ǯ5·î |
Âè92²óÆüËܾò½´ïɳزñÁí²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤòÇØ·Ê¤Ë¤ß¤é¤ì¤¿´ÎÆâ¿ȯ¾®·ëÀá¤Î°ìÎã |
| 2006ǯ5·î |
Âè42²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
PEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤Î¼£ÎŸú²Ìͽ¬¤Ë¤ª¤±¤ë¥¦¥¤¥ë¥¹dynamics¤Î¸¡Æ¤ |
| 2006ǯ5·î |
Âè42²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
PEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍѼ£ÎŤθú²Ìͽ¬¤Ë¤ª¤±¤ë2¡Ç-5¡Ç¥ª¥ê¥´¥¢¥Ç¥Ë¥ì¥¤¥È¹çÀ®¹ÚÁÇ¡Ê2-5AS¡Ë¤Î±þÅúÀ¤Î¸¡Æ¤ |
| 2006ǯ7·î |
Âè42²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤòÇØ·Ê¤Ë¤ß¤é¤ì¤¿´ÎÆâ¿ȯ¾®·ëÀá¤Î°ì¾ÉÎã |
| 2006ǯ7·î |
Âè42²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
CTA½ê¸«¤¬Ë³·ìÀ¤òÊݤ俤ޤޡ¢CTAP½ê¸«¤¬Ç»À÷¤«¤é6¥ö·î¤Î·Ð²á¤Çperfusion defect¤ËÊѲ½¤·¤¿¹âʬ²½´â¤Î¾ÉÎã |
| 2006ǯ7·î |
Âè42²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
ËýÀ´Î¼À´µ¤òÇØ·Ê¤È¤¹¤ë2cm°Ê²¼·ëÀá¤ÎCTA¡¦CTAP½ê¸«¤ÈÉÂÍý½ê¸«¤ÎÂÐÈæ |
| 2006ǯ9·î |
Âè85²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÉØÌÚ½¨°ì |
Åö±¡¤Ë¤Æ·Ð¸³¤·¤¿È󥦥¤¥ë¥¹ÀµÞÀ½Å¾É´Î¾ã³²¤Î3¾ÉÎã |
| 2006ǯ10·î |
DDW¡¡Japan¡¡2006 |
¶â¼éÎÉ |
PEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍѼ£ÎŤθú²Ìͽ¬¤Ë¤ª¤±¤ë2¡Ç-5¡Ç¥ª¥ê¥´¥¢¥Ç¥Ë¥ì¥¤¥È¹çÀ®¹ÚÁÇ¡Ê2-5AS¡Ë¤Î±þÅúÀ¤Î¸¡Æ¤ |
| 2006ǯ10·î |
DDW¡¡Japan¡¡2006 |
¶â¼éÎÉ |
CTA½ê¸«¤¬Ë³·ìÀ¤òÊݤ俤ޤޡ¢CTAP½ê¸«¤¬Ç»À÷¤«¤é6¥ö·î¤Î·Ð²á¤Çperfusion defect¤ËÊѲ½¤·¤¿¹âʬ²½´â¤Î¾ÉÎã |
| 2006ǯ10·î |
DDW¡¡Japan¡¡2006 |
¶â·¼Æó |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPeg-IFN¦Á2b¡¦¥ê¥Ð¥Ó¥ê¥óÎÅË¡¤Ë¤ª¤±¤ë¥Ý¥é¥×¥ì¥¸¥ó¥¯Ê»ÍѤˤè¤ë·ìµå¸º¾¯¤ª¤è¤Ó´Îµ¡Ç½¤ËÍ¿¤¨¤ë±Æ¶Á¤Ë¤Ä¤¤¤Æ¤Î¸¡Æ¤ |
| 2006ǯ10·î |
DDW¡¡Japan¡¡2006 |
°æËÜÊÙ |
AMA±¢À¤Î¤â¤ÈPBC¤È´Î¼Â¼Á¤ËµÞÀ´Î±êÍͽ긫¤ÈÃÀ½Á¤¦¤ÃÞü¤òǧ¤á¤¿AIH¤Î½ÅÊ£¾É¸õ·²¤Î°ì¾ÉÎã-ÆÃ¤ËÎ×¾²ÉÂÍý³ØÅª¸¡Æ¤ |
| 2006ǯ10·î |
DDW¡¡Japan¡¡2006 |
»°ÅÄ·ÉÆó |
½Ð·ì¸»¤¬ç£Æ°Ì®¤ÇÆâ»ë¶ÀŪ»ß·ì¤¬º¤Æñ¤Ç¤¢¤Ã¤¿½Ð·ìÀ°ßÄÙáç¤Î°ìÎã |
| 2007ǯ2·î |
Âè86²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÎëÌÚÆØ |
ÌôºÞÀ´Î¾ã³²¤ÎÆÃħŪÁÈ¿¥½ê¸«¤òÄ褷¤¿°ìÎã |
| 2007ǯ2·î |
Âè86²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÃöÀî¹°»Ì |
È󥢥륳¡¼¥ëÀ»éËÃÀ´Î±ê¡ÊNASH¡Ë¤Èñ½ã»éËôΤδÕÊ̤λî¤ß |
| 2007ǯ3·î |
APASL |
¶â¼éÎÉ |
Blood cell and liver function changes by PEG-IFN-¦Á2b
plus RBV with zinc |
| 2007ǯ3·î |
APASL |
¶â¼éÎÉ |
2'-5'-oligoadenylated synthetase response ration
predicting effect of PEG-IFN ¦Á2b plus Ribavirin |
| 2007ǯ4·î |
Âè93²óÆüËܾò½´ïɳزñÁí²ñ |
¶â¼éÎÉ |
¹âÎð¼ÔC·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN/Ribavirin¡ÊÊ»ÍÑÎÅË¡¡Ë¤Î¸¡Æ¤ |
| 2007ǯ4·î |
Âè93²óÆüËܾò½´ïɳزñÁí²ñ |
ÃöÀî¹°»Ì |
PIVKA¶°Û¾ï¹âÃͤòÄ褷¡¢Â¤±ÆCT¤Ë¤ÆÂ¿È¯¤¹¤ë¹ÈϤÊlow¡¡density¡¡area¤òǧ¤á¤¿¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤΰìÎã |
| 2007ǯ5·î |
Âè43²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
2£ã£í°Ê²¼¤Î·ëÀá¤ËÂФ¹¤ë¼è°·¤¤¤Ë¤Ä¤¤¤Æ¤ÎÄó¸À-·ì´É¤±Æ²¼CT¡¢À¸¸¡½ê¸«¤òƧ¤Þ¤¨¤Æ- |
| 2007ǯ5·î |
Âè43²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
PEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤Î¼£ÎŸú²Ì¤Ë´ØÏ¢¤¹¤ë½É¼ç¦°ø»Ò¤Î¸¡Æ¤-adipocytokine¡¢¥¤¥ó¥¹¥ê¥óÄñ¹³À¡¢´ÎÀþ°Ý²½¡¢ÈîËþ¤òÃæ¿´¤Ë |
| 2007ǯ5·î |
Âè43²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
PEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤Î¼£ÎŸú²Ìͽ¬¤Ë¤ª¤±¤ë¥¦¥¤¥ë¥¹dynamics¤Î¸¡Æ¤ |
| 2007ǯ5·î |
Âè43²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
PEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤Î¼£ÎŸú²Ìͽ¬¤Ë¤ª¤±¤ë2'-5'¥ª¥ê¥´¥¢¥Ç¥Ë¥ì¥¤¥È¹çÀ®¹ÚÁǤαþÅúÀ¤Î¸¡Æ¤ |
| 2007ǯ5·î |
Âè43²óÆüËܴΡ³Ø²ñÁí²ñ |
°æËÜÊÙ |
ËýÀC·¿´Î±ê¤Ë¤ª¤±¤ëËö¾¿·ìÃæ¤ÎIgG¹³·ì¾®ÈÄ´ØÏ¢ÆÃ°Û¼«¸Ê¹³ÂλºÀ¸BºÙ˦¤Î¸¡½Ð¤ª¤è¤Ó¤«¤«¤ëBºÙ˦½Ð¸½ÉÑÅÙ¤ÎIFN¼£ÎÅÁ°¸å¤Ë¤ª¤±¤ëÊÑÆ°-A¡¡pilot¡¡study |
| 2007ǯ6·î |
Âè43²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
CTA¤¬Ç»À÷¡¢CTAP¤âÇ»À÷¤·¤¿¹âʬ²½´ÎºÙ˦´â¤Î°ì¾ÉÎã |
| 2007ǯ6·î |
Âè43²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ë´Î¹ÅÊѤˤߤé¤ì¤¿Â¿È¯À¿·ìÀ·ëÀá¤Î2¾ÉÎã |
| 2007ǯ6·î |
Âè43²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
2cm°Ê²¼¤Î·ëÀá¤ËÂФ¹¤ë¼è°·¤¤¤Ë¤Ä¤¤¤Æ¤ÎÄó¸À-·ì´É¤±Æ²¼CT¡¢À¸¸¡½ê¸«¤òƧ¤Þ¤¨¤Æ- |
| 2007ǯ9·î |
SISL¡¡Seoul International Liver Symposium |
¶â¼éÎÉ |
Prediction of efficient virological response to
PEG-IFN/RBV combination therapy by NS5A sequences
of HCV in pre-treatment sera |
| 2007ǯ9·î |
Âè87²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÉØÌÚ½¨°ì |
AIH,PBC¡¡¥ª¡¼¥Ð¡¼¥é¥Ã¥×¾É¸õ·²¤Î°ìÎã |
| 2007ǯ9·î |
Âè183²óÆüËÜÆâ²Ê³Ø²ñ¶áµ¦ÃÏÊý²ñ |
ÅÄÃæÂçÊå |
ÃøÌÀ¤Ê·ì°µÊÑÆ°¤òǧ¤á¡¢Á޴ɲ¼¿Í¹©¸ÆµÛ´ï´ÉÍý¸å¤Ë¿ÇÃǤ¬¤Ä¤¤¤¿¥®¥é¥óŽ¥¥Ð¥ì¡¼¾É¸õ·²¤Î°ìÎã |
| 2007ǯ10·î |
JDDW2007¡¡Âè11²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN¦Á2b¡ÜRibavirin¡ÊÊ»ÍÑÎÅË¡¡Ë¤Ë¤ª¤±¤ë¥¤¥ó¥¹¥ê¥óÄñ¹³À¤È¼£ÎŸú²Ì¡¢´ÎÁÈ¿¥½ê¸«¡¢BMI¤È¤Î´ØÏ¢ |
| 2007ǯ10·î |
JDDW2007¡¡Âè11²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN¦Á2b¡ÜRibavirin¡ÊÊ»ÍÑÎÅË¡¡Ë¤Î¼£ÎŸú²Ì¤È¥«¥¹¥Ñ¡¼¥¼3³èÀ¤È¤Î´Ø·¸ |
| 2007ǯ10·î |
JDDW2007¡¡Âè11²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN¡¢Ribavirin¡ÊÊ»ÍÑÎÅË¡¡Ë¤Î¸ú²Ì¤È·ìÀ¶»é¼Á¥Þ¡¼¥«¡¼¤È¤Î´Ø·¸ |
| 2007ǯ12·î |
Âè37²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
PEG-IFN¡¢Ribavirin¤ÎÊ»ÍÑÎÅË¡½ªÎ»¸å¡¢10Æü¸å¤Ëµ¤´É»ÙÇÙ±ê¤ò¹çÊ»¤·¹³À¸ºÞ¤òÅêÍ¿¤·¤¿¤¬¡¢¤½¤Î10Æü¸å¤Ë´Ö¼ÁÀÇÙ±ê¤òȯ¾É¤·¤¿°ì¾ÉÎã |
| 2007ǯ12·î |
Âè37²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
2ǯȾ¤Î·Ð²á¤Ç¡¢Ã±½ãÀ»éËôΤ«¤éF2 stage¤ÎNASH¤Ë¿Ê¹Ô¤·¤¿1¾ÉÎã |
| 2007ǯ12·î |
Âè37²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ
|
¶â¼éÎÉ |
°ìÈÌɱ¡¤Ë¤ª¤±¤ëÀ¸Âδΰܿ¢¼£ÎŤΥÁ¡¼¥à°åÎÅ |
| 2007ǯ12·î |
Âè37²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
°æËÜÊÙ |
HLA DR4,DR8¤¬¸¡½Ð¤µ¤ì¤¿¤¬¡¢WBË¡¤Ç¤â¹³M2¹³ÂΤϱ¢À¤Ç¡¢¥¹¥Æ¥í¥¤¥É¤¬ÁÕ¸ù¤·¤¿AIH-PBC¡ÊAIC¡Ë½ÅÊ£¾É¸õ·²¤Î1Îã |
| 2008ǯ2·î |
Âè88²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£
|
PEG¡¡IFN¡Ü¥ê¥Ð¥Ó¥ê¥ó¼£ÎŸåµÚ¤Ó¼£ÎÅÃæ¤ËµÞÀç¹±ê¤òȯ¾É¤·¤¿C·¿ËýÀ´Î±ê¤Î£²Îã |
| 2008ǯ2·î |
Âè88²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
Ëܲ¬Ëãͳ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤòÇØ·Ê¤Ëacute on chronic¤Ë·à¾É´Î±ê¤òȯ¾É¤·¤¿¤¬¡¢ÊÝ¸Ū¼£ÎŤǵßÌ¿¤·ÆÀ¤¿£±Îã |
| 2008ǯ2·î |
Âè88²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÅÄÃæÂçÊå |
Àü¹¦ÀÊ¢Ëì±ê¤ò·Àµ¡¤Ëȯ¸«¤µ¤ì¤¿¾®Ä²·¿¥¯¥í¡¼¥óÉ¤Σ±Îã |
| 2008ǯ4·î |
Âè43²óEASL |
¶â¼éÎÉ |
Superiority of CT arterioportal angiography to
contrast-enhanced CT and MRI in the diagnosis of
hepatocellular carcinoma in nodules smaller than
2cm |
| 2008ǯ5·î |
Âè44²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤˤª¤±¤ë¿·ìÀ¿·ëÀáÀ·ëÀá |
| 2008ǯ5·î |
Âè44²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
˳·ìÀž°ÜÀ´Î¥«¥ë¥Á¥Î¥¤¥É¤Î1¾ÉÎã |
| 2008ǯ5·î |
Âè44²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
B·¿´Î¹ÅÊѤòÇØ·Ê¤Ë¤â¤Ä¹Å²½·¿HCC¤Î£±¾ÉÎã |
| 2008ǯ5·î |
Âè44²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
RFA¤Ç¤Ï¤Ê¤¯PEIT¼£ÎŤòÁªÂò¤·¤¿15mm°Ê²¼¹âʬ²½·¿´ÎºÙ˦´â¤Î3¾ÉÎã |
| 2008ǯ6·î |
Âè44²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
È󥢥륳¡¼¥ëÀ»éËÃÀ´Î±ê´µ¼Ô¡ÊNASH¡Ë¤Ë¤ª¤±¤ë´Î»éËò½¡¢´ÎÀþ°Ý²½¤Ë±Æ¶Á¤ò¤ª¤è¤Ü¤¹°ø»Ò¤Î¸¡Æ¤¡½adipocytokines¤òÃæ¿´¤Ë¡½ |
| 2008ǯ6·î |
Âè44²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
PEG¡¡IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤Î¼£ÎŸú²Ìͽ¬¤Ë¤ª¤±¤ë¥¦¥¤¥ë¥¹dynamics¤Î¸¡Æ¤ |
| 2008ǯ6·î |
Âè44²óÆüËܴΡ³Ø²ñÁí²ñ |
°æËÜÊÙ |
ËýÀC·¿´Î±ê¤Ë¤ª¤±¤ëËö¾¿·ìÃæ¤ÎIgG·¿¹³·ì¾®ÈÄÆÃ¼«¸Ê¹³ÂλºÀ¸BºÙ˦¤Î¸¡½ÐµÚ¤Ó¤«¤«¤ëBºÙ˦¿ô¤ÈËö¾¿·ì·ì¾®ÈÄ¿ô¤È¤Î´ØÏ¢À¤Ë¤Ä¤¤¤Æ |
| 2008ǯ9·î |
Âè89²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
À¾ÀîÎË |
Trousseau¾É¸õ·²¤È¿ÇÃǤµ¤ì¤¿ç¹´â´Î¿ȯž°Ü¤Î°ìÎã |
| 2008ǯ9·î |
Âè89²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
¹ýͺ°ìϯ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤηвáÃæ¤ËÆÃȯÀÊ¢¹ÐÆâ½Ð·ì¤òÄ褷¤¿2Îã |
| 2008ǯ10·î |
JDDW2008Âè12²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
ºßÆüÆüËܿ͡¢ºßÆü¥³¥ê¥¢¥ó¡¢ºßÃæ¹ñÃæ¹ñ¿Í¡¢ºßÃæ¹ñ¥³¥ê¥¢¥ó¤Ë¤ª¤±¤ëE·¿´Î±ê¥¦¥¤¥ë¥¹´¶À÷Ψ¤Ë´Ø¤¹¤ë±Ö³ØÅª¸¦µæ |
| 2008ǯ10·î |
JDDW2008Âè12²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
1b·¿¹â¥¦¥¤¥ë¥¹Î̹âÎð¼ÔC·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG IFN¦Á-2b/¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¡ÊÊ»ÍÑÎÅË¡¡Ë¤Î¸¡Æ¤-ȯ´âÍÞÀ©¤ÈÃæÃÇÂкö¤òÃæ¿´¤Ë- |
|
2008ǯ11·î
|
Âè187²óÆüËÜÆâ²Ê³Ø²ñ¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
ÈéÉæ¶Ú±ê¤òÇØ·Ê¤ËÊ¢ÉôËÄËþ¤ÇÍ象¤·¡¢µÞ®¤Ë»à¤Ë»ê¤Ã¤¿1˶¸¡Îã |
| 2008ǯ12·î |
Âè37²óÆüËܴΡ³Ø²ñÅìÉô²ñ |
¶â¼éÎÉ |
¥Ú¥°¥¤¥ó¥¿¡¼¥Õ¥§¥í¥ó¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¡ÊÊ»ÍÑÎÅË¡¡Ë¤Ë¤ª¤±¤ë¥¦¥¤¥ë¥¹Â¦SVR¡¢Non-SVRͽ¬°ø»Ò¤Î¸¡Æ¤µÚ¤ÓÁá´ü¥¦¥¤¥ë¥¹¥À¥¤¥Ê¥ß¥Ã¥¯¥¹¤È¤Î´Ø·¸ |
| 2008ǯ12·î |
Âè37²óÆüËܴΡ³Ø²ñÅìÉô²ñ |
¶â¼éÎÉ |
¥Ú¥°¥¤¥ó¥¿¡¼¥Õ¥§¥í¥ó¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¡ÊÊ»ÍÑÎÅË¡¡Ë¤ÇµÞÀç¹±ê¤ò¹çÊ»¤·¡¢16½µ¤ÇÃæÃǤ·¤¿¤¬¡¢Ãø¸ú¤È¤Ê¤Ã¤¿µb·¿¹â¥¦¥¤¥ë¥¹ÎÌC·¿ËýÀ´Î±ê¤Î°ì¾ÉÎã |
| 2009ǯ2·î |
Âè90²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
¹ýͺ°ìϯ |
µÞ®¤ËÁýÂ礷¤¿Êɳ°È¯°é·¿ÂçIJ´â¤Î£±Îã |
| 2009ǯ2·î |
Âè90²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
À¾ÀîÎË |
EOB¤±ÆMRI¤¬¿ÇÃǤËÍÍѤǤ¢¤Ã¤¿8mmÂç¹âʬ²½HCC¾ÉÎã |
| 2009ǯ4·î |
Âè44²ó¡¡EASL |
¶â¼éÎÉ |
Epidemiology of hepatitis in Northeastern Asia |
| 2009ǯ6·î |
Âè45²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
2cm°Ê²¼´Î´â¿ÇÃǤߤª¤±¤ëGD-EOB-DTPA¤±ÆMRI¡ÊEOB-MRI¡Ë¤ÎÍÍÑÀ |
| 2009ǯ6·î |
Âè45²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
´Ú¹ñºß½»´Ú¹ñ¿Í¤Ë¤ª¤±¤ëE·¿´Î±ê¥¦¥¤¥ë¥¹´¶À÷Ψ¤Ë´Ø¤¹¤ë±Ö³ØÅª¸¦µæ-ºßÆüÆüËܿ͡¢¥³¥ê¥¢¥ó¡¢ºßÃæ¹ñÃæ¹ñ¿Í¡¢¥³¥ê¥¢¥ó¤È¤ÎÈæ³Ó |
| 2009ǯ6·î |
Âè45²óÆüËܴΡ³Ø²ñÁí²ñ |
°æËÜÊÙ |
ËýÀC·¿´Î±ê¤Ë¤ª¤±¤ëËö¾¿·ì·ì¾®ÈÄ¿ô¸º¾¯¤Î¥á¥«¥Ë¥º¥à¤Ë¤Ä¤¤¤Æ-Ìȱַì±Õ³ØÅª¸¡º÷¤òÃæ¿´¤Ë- |
| 2009ǯ6·î |
Âè45²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
ºÙÃÀ´ÉºÙ˦´â¡ÊCoCC¡Ë¤Î2¾ÉÎã-Î×¾²ÉÂÍý³ØÅª¸¦µæ¤Î¸¡Æ¤- |
| 2009ǯ6·î |
Âè3²ó¹ñºÝ´Î´â¥·¥ó¥Ý¥¸¥¦¥à |
¶â¼éÎÉ |
Comparison of diagnostic ability of CECT, Sonazoid
CEUS, Gd-EOB-DTPA MRI, and CT arterioportal angiography
in diagnosing HCC in nodules smaller than 2cm |
| 2009ǯ7·î |
Âè45²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
2cm°Ê²¼Áá´ü´ÎºÙ˦´â¿ÇÃǤˤª¤±¤ë¤±ÆCT¡¢Â¤±ÆUS¡¢Gd-EOB-DTPA¡¡MRI¡ÊEOB¤±ÆMRI¡Ë¡¢Angio£Ã£Ô¤Î¿ÇÃÇǽ¤Î¸¡Æ¤ |
| 2009ǯ7·î |
Âè45²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
£Ã·¿´Î±ê¤òÇØ·Ê¤Ë7cmÂç´Î´âÀÚ½ü¸å18ǯ´ÖĹ´üÀ¸Â¸¤Î1¾ÉÎã |
| 2009ǯ7·î |
Âè45²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
˳·ìÀž°ÜÀ´Î¥«¥ë¥Á¥Î¥¤¥É¤Î1¾ÉÎã |
| 2009ǯ7·î |
Âè45²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
HCC¼£Î꤯ñÉô°Ì¤ËÂФ¹¤ë¥¬¥¤¥É¥ï¥¤¥ä¡¼¤Ë¤è¤ëRFA¼£ÎÅ |
| 2009ǯ7·î |
Âè45²óÆüËܴδ⸦µæ²ñ |
°æËÜ¡¡ÊÙ |
ÌäÂê¾ÉÎ㸡Ƥ²ñ |
| 2009ǯ9·î |
Âè91²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
Íû±Ñ¹À |
PBCÍͤÎÉÂÍý½ê¸«¤òÄ褷¤¿µÞÀÌôʪÀ´Î¾ã³²¤Î°ìÎã |
| 2009ǯ9·î |
Âè91²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÃæÅç·½°ì |
A-P shunt¤È¤·¤Æ4ǯ´Ö·Ð²á´Ñ»¡¤·¤Æ¤¤¤¿¤¬¡¢PIVKA-¶¤Î¾å¾º¤ò·Àµ¡¤È¤·¤Æ³Îǧ¤µ¤ì¤¿B·¿´ÎºÙ˦´â¤Î°ìÎã |
| 2009ǯ10·î |
JDDW2009Âè13²óÆüËܴΡ³Ø²ñÂç²ñ |
¿½ÌÀɱ |
Epidemiology of hepatitis E in Northeastern China,South
Korea, and Japan.¡Ê´ÎÆÃ´ë1-7¡Ë |
| 2009ǯ10·î |
JDDW2009Âè13²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
¥»¥í¥¿¥¤¥×2·¿C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëIFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤ÎÇØ·Ê°ø»ÒµÚ¤ÓÁá´ü¥¦¥¤¥ë¥¹dynamics¤Î¸¡Æ¤ |
| 2009ǯ10·î |
JDDW2009Âè13²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
1b·¿¹â¥¦¥¤¥ë¥¹C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN¡Ü¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅˡ̵¸úÎã¤ËÂФ¹¤ëÆó½Åßɲá·ìÞù¸ò´¹ÎÅË¡¤Î»î¤ß-¥¦¥¤¥ë¥¹dynamics¤òÃæ¿´¤Ë- |
| 2009ǯ10·î |
JDDW2009Âè13²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
2£ã£í°Ê²¼Áá´ü´ÎºÙ˦´â¿ÇÃǤˤª¤±¤ë¤±ÆCT¡¢Â¤±ÆUS¡¢EOB¤±ÆMRI¤Î¿ÇÃÇǽ¤Î¸¡Æ¤-Angio¡¡CT¤È¤ÎÈæ³Ó- |
| 2009ǯ10·î |
JDDW2009Âè13²óÆüËܴΡ³Ø²ñÂç²ñ |
ë¸ýÈþ¹¬ |
´Î¼À´µ¤ÎÉ¿ÇÏ¢·È-¿ÇΞðÊóÄó¶¡½ñ¤«¤é¸«¤¿Ê¼¸Ë¸©´Î¼À´µÀìÌç°åÎŵ¡´Ø¤ÎÌò³ä-¡Ê´ÎŽÜްޏ޼ޮޝŽÌŽß7¡Ë |
| 2009ǯ12·î |
Âè38²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
¥¤¥ó¥¿¡¼¥Õ¥§¥í¥óÅêÍ¿Ãæ¡¢¼«¸ÊÌȱÖÀ·ì¾®ÈÄ»çÈÃÉ¡ÊAITP¡Ë¤òȯ¾É¤·¤¿C·¿ËýÀ´Î±ê¤Î1¾ÉÎã |
| 2009ǯ12·î |
Âè38²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
°æËÜÊÙ |
C·¿´ØÏ¢´Î¹ÅÊѤòÇØ·Ê¤Ëslow growing ¹âʬ²½HCC¤È¡¢Â¿¿ô¤Î¹¥Ãæµå¿»½á¤òȼ¤¤CD56ÍÛÀºÙ˦¤¬»¶¸«¤µ¤ì¤¿rapid
growing HCC¤¬¡¢°Û½êÀ¤ËȯÀ¸¤·¤¿1Îã |
| 2010ǯ2·î |
Âè25²óÆüËÜÀÅÌ®·ÐIJ±ÉÍܳزñ |
°ÂÆ£·ò¼£ |
·ìÀ¶°¡±ô¤Î±ÉÍÜ¡¢êóáìɾ²Á¤Ë¤ª¤±¤ëÍÍÑÀ¤Ë¤Ä¤¤¤Æ |
| 2010ǯ2·î |
Âè92²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
Íû±Ñ¹À |
EOB¤±ÆMRI¤¬¿ÇÃǤËÍÍѤǤ¢¤Ã¤¿1cm°Ê²¼¤Î¹âʬ²½´ÎºÙ˦´â¤Î2¾ÉÎã |
| 2010ǯ2·î |
Âè92²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÃæÅç·½°ì |
²¼Éô¾Ã²½´ÉÆâ»ë¶À¸¡ºº¸å¡¢¤¿¤³¤Ä¤Ü·¿¿´¶Ú¾É¤Ë¤è¤ê¿´¸¶À¥·¥ç¥Ã¥¯¤Ë»ê¤Ã¤¿¤¬¡¢½¸ÃæÅª¿´ÇÙÁÉÀ¸¤Ë¤è¤êµßÌ¿¤·¤¨¤¿°ì¾ÉÎã |
| 2010ǯ4·î |
Âè45²ó²¤½£´Î¡³Ø²ñ¡ÊEASL¡Ë |
¶â¼éÎÉ |
Comparison of diagnostic capability of contrast-enhanced
CT, Sonazoid contrast-enhanced US, Gd-EOB-DTPA MRI
and CT arterioportal angiography in detecting histologically
proven HCC nodules smaller than 2cm¡¡ |
| 2010ǯ5·î |
Âè46²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
1b·¿¹â¥¦¥¤¥ë¥¹C·¿ËýÀ´Î±ê¤ÎPEG-IFN+¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅˡ̵¸úÎã¤ËÂФ¹¤ëÆó½Åßɲá·ìÞù¸ò´¹ÎÅË¡¡ÜIFN-¦Â
4½µ´ÖϢ³ÅêÍ¿¤Î»î¤ß |
| 2010ǯ5·î |
Âè46²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
2cm°Ê²¼´ÎºÙ˦´â¿ÇÃǤˤª¤±¤ë¤±ÆCT¡¤Â¤±ÆUS¡¤Angio CT ¤Î¿ÇÃÇǽ¤Î¸¡Æ¤¡ÝEOB¤±ÆMRI¤È¤ÎÈæ³Ó¡Ý |
| 2010ǯ5·î |
Âè46²óÆüËܴΡ³Ø²ñÁí²ñ |
°æËÜÊÙ |
C·¿´Î¹ÅÊѾÉÎã¤ËÂФ¹¤ëPSE»Ü¹Ô¸å¤ÎËö¾¿·ì·ì¾®ÈÄ¿ôÁý²ÃÎãµÚ¤ÓÉÔ±þÎã¤Ë¤Ä¤¤¤Æ¤ÎÌȱַì±Õ³ØÅª¸¡Æ¤ |
| 2010ǯ5·î |
Âè46²óÆüËܴΡ³Ø²ñÁí²ñ |
ËÙÅÄ¡¡Çî
El-Shamy
¶â¼éÎÉ |
ËýÀC·¿´Î±ê¤ËÂФ¹¤ëPEG-IFN¡¿RBV¼£ÎŸú²Ì¤ËµÚ¤Ü¤¹¥¦¥¤¥ë¥¹Â¦°ø»Ò¤Î¤µ¤é¤Ê¤ë¸¡Æ¤¡§¡¡HCV-2aµÚ¤ÓHCV-2b¤ÎNS5A¿ÍÍÀ¤Ï¼£ÎŸú²Ì¤ÈÁê´Ø¤¹¤ë |
| 2010ǯ6·î |
¹ñºÝ¹âÎï³Ø²ñÆüËÜ»ÙÉôÂè14²ó³Ø½ÑÂç²ñ |
¶â¼éÎÉ |
Epidemiology of hepatitis E in Northeastern China,South
Korea, and Japan. |
| 2010ǯ7·î |
Âè46²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
2cm°Ê²¼ºÙ¾®´ÎºÙ˦´â¿ÇÃǤˤª¤±¤ë¤±ÆCT¡¤Â¤±ÆUS¡¤EOB¤±ÆMRI¤Î¿ÇÃÇǽ¤Î¸¡Æ¤¡ÝAngio
CT¤È¤ÎÈæ³Ó¡Ý |
| 2010ǯ7·î |
Âè46²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
²èÁü¾åCCC¤È´ÕÊ̺¤Æñ¤Ç¤¢¤Ã¤¿Clear cell HCC¤Î¾ÉÎã |
| 2010ǯ7·î |
Âè46²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
A-P shunt¤È¤·¤Æ4ǯ´Ö·Ð²á´Ñ»¡¤·¤Æ¤¤¤¿¤¬¡¢PIVKA-¶¤Î¾å¾º¤ò·Àµ¡¤È¤·¤Æ³Îǧ¤µ¤ì¤¿B·¿´ÎºÙ˦´â¤Î°ìÎã |
| 2010ǯ7·î |
Âè46²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
ÌäÂê¾ÉÎ㸡Ƥ²ñ¡ÊCoCC¡Ë |
| 2010ǯ7·î |
Âè46²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
ÌäÂê¾ÉÎ㸡Ƥ²ñ¡Ê»ÒµÜ´â¡Ë |
| 2010ǯ9·î |
Âè192²óÆüËÜÆâ²Ê³Ø²ñ¶áµ¦ÃÏÊý²ñ |
°ÂÆ£·ò¼£ |
C·¿´Î±ê¤òÇØ·Ê¤Ë7cmÂç´Î´âÀÚ½ü¸å20ǯ´ÖĹ´üÀ¸Â¸¤Î1¾ÉÎã |
| 2010ǯ9·î |
Âè93²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
¶â¼éÎÉ |
¿ÇÃǺ¤Æñ¤Ê磸¶È¯¼ðáç¤Î°ìÎã |
| 2010ǯ10·î |
Âè14²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
2cm°Ê²¼ºÙ¾®´Î´â¿ÇÃǤˤª¤±¤ë¤±ÆCT¡¢Â¤±ÆUS¡¢EOB¤±ÆMRI¡¢Angio CT¤Î¿ÇÃÇǽ¤Î¸¡Æ¤ |
| 2010ǯ10·î |
Âè14²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
C·¿´Î¹ÅÊÑ¡¢¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤòÇØ·Ê¤Ë´ÎºÙ˦´â¡¢´ÎÆâÃÀ´ÉºÙ˦´â¡¢ºÙÃÀ´ÉºÙ˦´â¤¬Â¿Ãæ¿´À¤ËȯÀ¸¤·¤¿2¾ÉÎ㡽CoCC¤ÎÌȱÖÁÈ¿¥³ØÅª¸¡Æ¤¤ò´Þ¤ó¤Ç¡½ |
| 2010ǯ10·î |
Âè14²óÆüËܴΡ³Ø²ñÂç²ñ |
°æËÜÊÙ |
C·¿ËýÀ´Î±ê1b·¿¹â¥¦¥¤¥ë¥¹ÎÌÊ»ÍÑÎÅˡ̵¸ú´µ¼Ô¤ËÂФ¹¤ëÆó½Åßɲá·ìÞù¸ò´¹ÎÅË¡¡ÊDFPP¡Ë+IFN¦Â2¡Á4½µÏ¢Â³ÅêÍ¿¸åPEG-IFN¦Á-2a+RBVÊ»ÍÑÎÅË¡¤ÎÁá´ü¥¦¥¤¥ë¥¹¥À¥¤¥Ê¥ß¥Ã¥¯¥¹¤Ë¤è¤ëEVRͽ¬ |
| 2010ǯ10·î |
Âè14²óÆüËܴΡ³Ø²ñÂç²ñ |
°æËÜÊÙ |
1b·¿¹â¥¦¥¤¥ë¥¹ÎÌC·¿ËýÀ´Î±ê¤ÎPEG-IFN+RBVÊ»ÍÑÎÅˡ̵¸úÎã¤ËÂФ¹¤ëÆó½Åßɲá·ìÞù¸ò´¹ÎÅË¡¡ÊDFPP¡Ë+IFN¦Â4½µ´ÖϢ³ÅêÍ¿¸åPEG-IFN¦Á-2a+RBV¤Î»î¤ß |
| 2011ǯ2·î |
Âè94²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
²»ÌîͳÈþ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤòÇØ·Ê¤Ë²èÁü¾å¡ÊEOB MRI, ·ì´É¤±ÆCT¤ò´Þ¤à¡Ëŵ·¿ÅªHCC pattern¤ò¤È¤Ã¤¿15mmÂç¸Â¶ÉÀ·ëÀáÀ²á·ÁÀ®¡ÊFNH¡ËÍÍ·ëÀá¤Î°ìÎã |